PHARMASEAL Launches Engility CTMS


Applied Clinical Trials

PHARMASEAL, a new provider of clinical trial management and governance solutions, has launched Engility CTMS, the first product to be released from its Engility B2B platform. This new CTMS has been designed in hopes to increase the level of governance and control that organizations demand from their management systems to enable effective oversight of their clinical trials.

Read the full release here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.